The Bioscientifica Trust has been established to offer funding to assist early-career scientists and clinicians in biomedicine and the life sciences.
Bioscientifica are delighted to announce a partnership with Sheridan PubFactory that will see all titles published by Bioscientifica hosted on the PubFactory platform from Summer 2018. This partnership will enable heightened service to society partners.
Bioscientifica have again announced substantial growth in the impact factors of their biomedical journals in the latest Journal Citation Reports (JCR).
Environmental temperatures of over 25 degrees are associated with a significant increase in the risk of being misdiagnosed with gestational diabetes during pregnancy, data published in the European Journal of Endocrinology suggests. Misdiagnosis of the condition could lead to unnecessary insulin treatment and avoidable distress for prospective mothers.
New guidelines for managing recurrent pituitary tumours identify the drug temozolomide, as first line chemotherapy treatment. The guidelines, published in the European Journal of Endocrinology and produced by the European Society of Endocrinology (ESE), include a series of recommendations aimed at improving survival rates and quality of life for patients, through early identification of tumours and more effective treatment strategies.